In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio
Email Updates
Search
Message: NEWS - AlphaRx Announces Debt Conversion
Reply New Message
« Prev Message Back To Forum Go to Threaded View Next Message »
Admin_profile
AGORACOM
Rank: [?]
Administrator
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: NEWS - AlphaRx Announces Debt Conversion

in response to Re: NEWS - AlphaRx Announces Debt Conversion by jackfree
posted on Sep 28, 07 01:08PM
jackfree, 

Thank you for your inquiry. The float will be increased by 24,382,813 shares and the conversion price was at .05 cents. All restricted shares will hold for 2 years and the deal was done over a month ago. 

Regards,
AGORACOM Investor Relations
Reply New Message
« Prev Message Back To Forum Go to Threaded View Next Message »
New Message

Please login to post a reply

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote